Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to compare the effect of enhanced probiotic (EP, Live Rx) versus placebo (PL) on the incidence of Clostridium difficile associated diarrhea (CDAD) or antibiotic associated diarrhea (AAD) in hospitalized patients initiated on antibiotics.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)


Related Conditions & MeSH terms


NCT number NCT01596153
Study type Interventional
Source South Shore Hospital
Contact
Status Withdrawn
Phase N/A

See also
  Status Clinical Trial Phase
Terminated NCT01972932 - Study of Bio-K+® in the Reduction of the Risk of Clostridium Difficile Infection and Antibiotic Associated Diarrhea Phase 4
Completed NCT02765217 - Effect of Lactobacillus Reuteri DSM 17938 to Prevent Antibiotic-associated Diarrhea in Children Phase 4
Completed NCT01295918 - Probiotic Lactobacillus Reuteri to Prevent Antibiotic-associated Diarrhea and Clostridium Difficile-related Infections in Hospitalized Children Phase 3
Completed NCT02871908 - Lactobacillus Reuteri DSM 17938 in the Prevention of Antibiotic-associated Diarrhea in Children: Protocol of a Randomized Controlled Trial Phase 4
Completed NCT01941160 - Effect of a Lacidofil® STRONG in Healthy Adults Taking Antibiotic Treatment Phase 1/Phase 2